Business
Haysmacintyre advises CRISM on reverse takeover of Extruded
The strategic acquisition marks CRISM’s transition from mineral exploration to a focus on pharmaceutical advancements
Haysmacintyre has provided reporting accountant services for CRISM Therapeutics Corporation’s reverse takeover of Extruded Pharmaceuticals Limited.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
